A Novel Computationally Designed Multibody Targeting IL-13/TSLP for Precision Therapy in TH2-Mediated Diseases | Biolojic Design

Categories: Publication | Published On: May 14, 2024 | Written by webadmin@biolojic.com |

A Novel Computationally Designed Multibody Targeting IL-13/TSLP for Precision Therapy in TH2-Mediated Diseases

More News

A novel therapeutically active anti-TNFR2 agonistic antibody promotes Treg proliferation and induction of Treg functional markers
Read More
Redirecting an anti-IL-1β antibody to bind a new, unrelated and computationally predicted epitope on hIL-17A
Read More

BUSINESS AND MEDIA INQUIRIES

Micah Pearlman
micah@biolojic.com